The IFFO2 gene, denoting the Intermediate Filament Family Orphan 2, presents a unique and enigmatic target within the cellular landscape. Predicted to be located in intermediate filaments, this gene hints at a role in shaping the structural framework of the cell. Intermediate filaments play a critical role in maintaining cellular integrity, providing mechanical support, and participating in various signaling pathways. As an orphan gene, IFFO2 lacks well-established direct activators, challenging researchers to unravel its intricate regulatory network. While the specific function of IFFO2 remains elusive, its predicted localization in intermediate filaments suggests a role in cellular architecture, potentially influencing processes such as cytoskeletal organization, cell motility, and structural stability.
Activation of IFFO2 is intricately linked to the modulation of signaling pathways that impact intermediate filament dynamics. Understanding the broader cellular context is crucial for delineating potential mechanisms of activation. Various chemical modulators, as identified in the previous table, exert their influence on key cellular components like protein kinases and phosphatases, impacting processes such as phosphorylation, vesicular trafficking, and MAPK signaling. The indirect activation of IFFO2 is hypothesized to occur through the alteration of intermediate filament dynamics mediated by these chemical interventions. For example, inhibition of specific protein kinases, such as PKC, may disrupt downstream signaling cascades that regulate intermediate filament-associated processes, creating an environment conducive to IFFO2 activation. Similarly, modulation of PI3-kinase or MAPK pathways may indirectly influence intermediate filaments, providing a context in which IFFO2 activation becomes more plausible. The interplay between these chemicals and cellular processes highlights the intricate regulatory landscape surrounding IFFO2, underscoring the need for further investigation into the precise mechanisms that govern its activation within the cellular milieu. In summary, while the exact function of IFFO2 is yet to be fully elucidated, its predicted involvement in intermediate filaments positions it as a potential regulator of cellular architecture, with activation likely orchestrated through the intricate modulation of key signaling pathways and associated cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Potent PKC activator, influencing cellular processes. Binds and activates PKC, leading to downstream signaling cascades. PKC activation may indirectly impact IFFO2 through various pathways, modulating gene expression and intermediate filament dynamics, potentially activating IFFO2 in a signal transduction-dependent manner. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Ser/Thr phosphatase inhibitor, affecting cellular processes. Blocks PP1 and PP2A, influencing phosphorylation events. The intricate interplay between phosphatases and kinases might indirectly activate IFFO2 by altering the phosphorylation status of intermediate filament-associated proteins, thereby influencing the cellular context and promoting IFFO2 activation. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Broad-spectrum PKC inhibitor affecting cellular processes. By blocking PKC isoforms, Go6983 may indirectly influence IFFO2 activation. PKC-mediated pathways impact cellular functions, including intermediate filament organization, and Go6983's action on these pathways may lead to alterations in the cellular context, indirectly activating IFFO2. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Selective PKC inhibitor with potential indirect effects on IFFO2. Modulates PKC-dependent pathways that influence cellular processes, including intermediate filament dynamics. By blocking specific PKC isoforms, Bisindolylmaleimide I may indirectly activate IFFO2 through downstream signaling events that impact intermediate filament organization and promote conditions supportive of IFFO2 activation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor modulating cellular processes. By inhibiting mTOR, Rapamycin may indirectly impact IFFO2 activation. mTOR-dependent pathways influence various cellular functions, including intermediate filament dynamics. Rapamycin's action on these pathways may alter the cellular context, promoting conditions conducive to IFFO2 activation indirectly. | ||||||
Ro 31-8220 | 138489-18-6 | sc-200619 sc-200619A | 1 mg 5 mg | $92.00 $245.00 | 17 | |
Broad-spectrum PKC inhibitor with potential indirect effects on IFFO2. Modulates PKC-dependent pathways that influence cellular processes, including intermediate filament dynamics. By blocking specific PKC isoforms, Ro 31-8220 may indirectly activate IFFO2 through downstream signaling events that impact intermediate filament organization and promote conditions supportive of IFFO2 activation. | ||||||